![]() The increased potential (in adolescents compared with adults) for weight gain and dyslipidemia may lead clinicians toĬonsider prescribing other drugs first in adolescents. ![]() ![]() Adolescents (ages 13 to 17): Efficacy was established in one 3-week trial in patients with manic or mixed episodes associated with bipolarġ4.2).Adults: Efficacy was established in three clinical trials in patients with manic or mixed episodes of bipolar I disorder: two 3- to 4-week trials.Acute treatment of manic or mixed episodes associated with bipolar I disorder and maintenance treatment of bipolar I disorder.Adolescents (ages 13 to 17): Efficacy was established in one 6-week trial in patients with schizophrenia (Īdolescents compared with adults) for weight gain and dyslipidemia may lead clinicians to consider prescribing other drugs first in.Adults: Efficacy was established in three clinical trials in patients with schizophrenia: two 6-week trials and one maintenance trial.Olanzapine is an atypical antipsychotic indicated:
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |